4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A clinical guide to using Wegovy (semaglutide 2.4 mg) in adults aged 65 and older, covering exercise safety, fall risk, sarcopenia, cognitive engagement programs, and activity modifications backed by trial data and geriatric guidelines.
A clinically detailed guide to starting, continuing, or transitioning onto Wegovy (semaglutide 2.4 mg) in patients aged 65 and older, covering dosing, safety, muscle loss, polypharmacy, and what geriatric guidelines actually say.
A guide to Wegovy (semaglutide 2.4 mg) administration for patients aged 65 and older, covering injection technique, dose escalation, fall and nutrition risks, and practical caregiver protocols.
A comprehensive clinical review of semaglutide 2.4 mg (Wegovy) use in patients aged 65+, covering efficacy, muscle and bone loss risks, nutritional considerations, dose titration, and updated geriatric prescribing guidance.